Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells-Reference-Cited by-同舟云学术

Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells

Published:2020-04 Issue:5 Volume:106 Page:1039-1051
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Bourillon Laura,Demontoy Sylvain,Lenglet Alexis,Zampieri Alexandre,Fraisse Julien,Jarlier Marta,Boissière-Michot Florence,Perrochia Hélène,Rathat Gauthier^ORCID,Garambois Véronique,Bonnefoy Nathalie,Michaud Henri-Alexandre,Chardès Thierry^ORCID,Tosi Diego,Pèlegrin André,Azria David,Larbouret Christel,Bourgier Céline

Funder

SIRIC Montpellier Cancer

LabEx MabImprove

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference33 articles.

1. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01;Eifel;J Clin Oncol,2004

2. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: Individual patient data meta-analysis;Cochrane Database Syst Rev,2010

3. Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: A systematic review;Noordhuis;Int J Radiat Oncol Biol Phys,2011

4. Negative prognostic impact of the coexpression of epidermal growth factor receptor and C-ERBB-2 in locally advanced cervical cancer;Perez-Regadera;Oncology,2009

5. Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer;Noordhuis;Clin Cancer Res,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific antibody drug conjugates: Making 1+1>2;Acta Pharmaceutica Sinica B;2024-05

2. Monoclonal antibodies for the treatment of squamous cell carcinoma: A literature review;Cancer Reports;2023-04-12

3. HER3 in cancer: from the bench to the bedside;Journal of Experimental & Clinical Cancer Research;2022-10-21

4. Significant growth inhibition by a bispecific affibody targeting oncoprotein E7 in both HPV16 and 18 positive cervical cancer in vitro and in vivo;European Journal of Pharmaceutical Sciences;2022-05

5. Prognostic Significance of HER3 Expression in Patients with Cervical Cancer;Cancers;2022-04-25